Adjunctive Passive Immunotherapy in Human Immunodeficiency Virus Type 1-Infected Individuals Treated with Antiviral Therapy during Acute and Early Infection

Three neutralizing monoclonal antibodies (MAbs), 2G12, 2F5, and 4E10, with activity in vitro and in vivo were administered in an open-label, nonrandomized, proof-of-concept study to attempt to prevent viral rebound after interruption of antiretroviral therapy (ART). Ten human immunodeficiency virus...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Mehandru, Saurabh, Vcelar, Brigitta, Wrin, Terri, Stiegler, Gabriela, Joos, Beda, Mohri, Hiroshi, Boden, Daniel, Galovich, Justin, Tenner-Racz, Klara, Racz, Paul, Carrington, Mary, Petropoulos, Christos, Katinger, Hermann, Markowitz, Martin
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2007
Assuntos:
Vaccines and Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2045579/
https://ncbi.nlm.nih.gov/pubmed/17686878
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.01340-07
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados